ATTACHMENT A: 
Roster 
ATTACHMENT B: 
Excerpts from the June 1, 1990, Human Gene Therapy 
Subcommittee on the Presentation and Discussion of Proposed 
Addition to Appendix D of the NIH Guidelines (Human Gene 
Therapy Clinical Protocol — Adenosine Deaminase Deficiency) 
ATTACHMENT C: 
Excepts from the July 30, 1990, Human Gene Therapy 
Subcommittee on the Proposed Additions to Appendix D of the 
NIH Guidelines Regarding Human Gene Therapy Protocols 
entitled "Treatment of Severe Combined Immunodeficiency 
Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency 
with Autologous Lymphocytes Transduced with a Human ADA 
Gene" and entitled "Gene Therapy of Patients with Advanced 
Cancer using Tumor Infiltrating Lymphocytes Transduced with 
the Gene Coding for Tumor Necrosis Factor" 
ATTACHMENT D: 
Excerpts From the July 30, 1990, Human Gene Therapy 
Subcommittee on the Proposed Addition to Appendix D of the 
NIH Guidelines Regarding Human Gene Transfer Clinical 
Protocol entitled "Use of Marker Genes to Investigate the 
Biology of Marrow Reconstitution and Relapse of Malignant 
Disease Following Autologous Bone Marrow Transplantation" 
[ 110 ] 
Recombinant DNA Research, Volume 14 
